SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001564590-22-016080
Filing Date
2022-04-27
Accepted
2022-04-27 16:27:25
Documents
5
Period of Report
2022-06-16

Document Format Files

Seq Description Document Type Size
1 DEF 14A pstx-def14a_20220616.htm DEF 14A 843344
2 GRAPHIC gsin5ayeey0d000004.jpg GRAPHIC 36837
3 GRAPHIC gsin5ayeey0d000001.jpg GRAPHIC 32204
4 GRAPHIC gsin5ayeey0d000002.jpg GRAPHIC 32204
5 GRAPHIC gsin5ayeey0d000003.jpg GRAPHIC 61278
  Complete submission text file 0001564590-22-016080.txt   1068809
Mailing Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121
Business Address 9390 TOWNE CENTRE DRIVE SUITE 200 SAN DIEGO CA 92121 858-779-3100
Poseida Therapeutics, Inc. (Filer) CIK: 0001661460 (see all company filings)

IRS No.: 472846548 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-39376 | Film No.: 22860030
SIC: 2836 Biological Products, (No Diagnostic Substances)